RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Peter R. Hoffmann to Ovarian Neoplasms

This is a "connection" page, showing publications Peter R. Hoffmann has written about Ovarian Neoplasms.
Connection Strength

0.601
  1. Weiland F, Arentz G, Klingler-Hoffmann M, McCarthy P, Lokman NA, Kaur G, Oehler MK, Hoffmann P. Novel IEF Peptide Fractionation Method Reveals a Detailed Profile of N-Terminal Acetylation in Chemotherapy-Responsive and -Resistant Ovarian Cancer Cells. J Proteome Res. 2016 11 04; 15(11):4073-4081.
    View in: PubMed
    Score: 0.373
  2. Ricciardelli C, Lokman NA, Cheruvu S, Tan IA, Ween MP, Pyragius CE, Ruszkiewicz A, Hoffmann P, Oehler MK. Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation. Clin Exp Metastasis. 2015 Jun; 32(5):441-55.
    View in: PubMed
    Score: 0.084
  3. Lokman NA, Elder AS, Ween MP, Pyragius CE, Hoffmann P, Oehler MK, Ricciardelli C. Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis. Oncotarget. 2013 Aug; 4(8):1199-211.
    View in: PubMed
    Score: 0.075
  4. Gustafsson JOR, Eddes JS, Meding S, Koudelka T, Oehler MK, McColl SR, Hoffmann P. Internal calibrants allow high accuracy peptide matching between MALDI imaging MS and LC-MS/MS. J Proteomics. 2012 Aug 30; 75(16):5093-5105.
    View in: PubMed
    Score: 0.069
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support